Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![GravAnalytica Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1874146095762153473.png) Gravity Analytica News [@GravAnalytica](/creator/twitter/GravAnalytica) on x XX followers
Created: 2025-07-21 11:06:09 UTC

$GLUE Monte Rosa Therapeutics Announces First Subjects Dosed in Phase X Study of MRT-8102, a NEK7-Directed Molecular Glue Degrader for the Treatment of Multiple Inflammatory Diseases




#biotechs


XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1947251748973818114/c:line.svg)

**Related Topics**
[$glue](/topic/$glue)

[Post Link](https://x.com/GravAnalytica/status/1947251748973818114)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

GravAnalytica Avatar Gravity Analytica News @GravAnalytica on x XX followers Created: 2025-07-21 11:06:09 UTC

$GLUE Monte Rosa Therapeutics Announces First Subjects Dosed in Phase X Study of MRT-8102, a NEK7-Directed Molecular Glue Degrader for the Treatment of Multiple Inflammatory Diseases

#biotechs

XX engagements

Engagements Line Chart

Related Topics $glue

Post Link

post/tweet::1947251748973818114
/post/tweet::1947251748973818114